+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antiseptics and Disinfectants Market Size, Share & Trends Analysis Report By Type (Quaternary Ammonium, Chlorine), Product Type (Medical Device Disinfectants), By End Use, And Segment Forecasts, 2019 - 2026

  • ID: 4751808
  • Report
  • 79 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • 3M
  • BD
  • Cardinal Health
  • JOHNSON & JOHNSON
  • Novartis AG
  • STERIS Plc
  • MORE
The global antiseptics and disinfectants market size is expected to reach USD 27.99 billion by 2026. It is anticipated to expand at a CAGR of 6.7% during the forecast period. Increasing prevalence of Hospital-acquired Infections (HAIs), awareness about home cleanliness and the need for disinfection, and usage of endoscope reprocesses and surgical units across the globe are the key driving factors.

Rising use of Gastrointestinal (GI) endoscopes and surgical units due to the increasing rate of surgeries across the globe is expected to drive the antiseptics and disinfectants market growth over the forecast period. GI endoscopy is one of the important tools for the treatment and identification of disorders of the gastrointestinal tract. Proper understandings of application to GI endoscopy and infection control is very much essential as it helps to prevent transmission of infection through endoscopes and lapses in reprocessing.

Moreover, endoscopes need to be reprocessed appropriately as per the infection-control guidelines to lower the risk of acquiring environmental or patient-borne microorganisms. Thus, in such cases application of proper antiseptics and disinfectant solutions are very much essential to prevent transmission of infections. In addition, increasing rate of endoscopy is expected to surge the risk of getting such infections.

For instance, as per the BMJ Publishing Group Ltd & British Society of Gastroenterology, published in 2018, the demand for gastrointestinal endoscopy has grown immensely for both and bowel cancer screening and symptomatic patients owing to which overall demand has doubled in many centers in U.K. over the last five years. Such factors are anticipated to drive the growth of antiseptics & disinfectants market.

Further key findings from the report suggest:
  • In terms of revenue, quaternary ammonium compounds segment is expected to hold the largest market share over the forecast period. High prevalence of HAIs is the major factor driving the growth
  • Enzymatic cleaners are expected to witness the fastest growth over the forecast period. Increasing rate of surgeries is expected to drive the segment growth as the product is majorly used for disinfection of surgical kits
  • Asia-Pacific antiseptics and disinfectants market is expected to witness the fastest growth over the forecast period owing to the increasing number of hospitals and clinics
  • Prominent market players are BD, Johnson & Johnson, Novartis AG, and Cardinal Health.


Please Note: This report will be delivered within 48 hours of ordering.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M
  • BD
  • Cardinal Health
  • JOHNSON & JOHNSON
  • Novartis AG
  • STERIS Plc
  • MORE
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline

Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Region Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity flow analysis (Model 1)
2.6.2 Volume price analysis (model 2)
2.7 List of Secondary Sources

Chapter 3 Objectives
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the strategy framework and competitor categorization
3.4 Objective - 4: Understanding the scope of the market

Chapter 4 Executive Summary

Chapter 5 Market Definition

Chapter 6 Industry Outlook
6.1 Market Segmentation
6.2 Market Variable Analysis
6.2.1 Market driver analysis
6.2.1.1 Increasing prevalence of hospital acquired diseases
6.2.1.2 Increasing use of endoscope reprocesses and surgical units
6.2.2 Market restraint analysis
6.2.2.1 Stringent regulations related to usage of antiseptics & disinfectants
6.2.2.2 Lack of relevant knowledge in developing countries
6.3 Penetration & Growth Prospect Mapping
6.4 Business Environment Analysis tools
6.4.1 SWOT Analysis, by PEST
6.4.2 Porter’s five forces analysis

Chapter 7 Type Segment Analysis
7.1 Antiseptics & Disinfectants Market: Type Movement Analysis
7.2 Quaternary Ammonium Compounds
7.2.1 Quaternary ammonium compounds Market, 2014-2026 (USD Million)
7.3 Chlorine Compounds
7.3.1 Chlorine compounds market, 2014-2026 (USD Million)
7.4 Alcohols & Aldehyde Products
7.4.1 Alcohols & aldehyde products market, 2014-2026 (USD Million)
7.5 Enzymes
7.5.1 Enzymes market, 2014-2026 (USD Million)
7.6 Others
7.6.1 Others market, 2014-2026 (USD Million)

Chapter 8 Product Type Segment Analysis
8.1 Antiseptics & Disinfectants Market: Product Type Movement Analysis
8.2 Enzymatic Cleaners
8.2.1 Enzymatic cleaners market, 2014-2026 (USD Million)
8.3 Medical Device Disinfectants
8.3.1 Medical device disinfectants market, 2014-2026 (USD Million)
8.4 Surface Disinfectants
8.4.1 Surface disinfectants market, 2014-2026 (USD Million)

Chapter 9 End Use Segment Analysis
9.1 Antiseptics & Disinfectants Market: End Use Movement Analysis
9.2 Hospitals
9.2.1 Hospitals market, 2014-2026 (USD Million)
9.3 Clinics
9.3.1 Clinics market, 2014-2026 (USD Million)
9.4 Others
9.4.1 Others market, 2014-2026 (USD Million)

Chapter 10 Regional Outlook
10.1 Antiseptics & Disinfectants Market Share by Region, 2018 & 2026
10.2 North America
10.2.1 North America Antiseptics & Disinfectants market, 2014 - 2026 (USD Million)
10.2.2 U.S.
10.2.2.1 U.S. antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.2.3 Canada
10.2.3.1 Canada antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.3 Europe
10.3.1 Europe antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.3.2 U.K.
10.3.2.1 U.K. antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.3.3 Germany
10.3.3.1 Germany antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.4.2 Japan
10.4.2.1 Japan antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.4.3 China
10.4.3.1 China antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.5 Latin America
10.5.1 Latin America antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.6 MEA
10.6.1 MEA antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.6.2 South Africa
10.6.2.1 South Africa antiseptic & disinfectant market, 2014 - 2026 (USD Million)
10.6.3 Saudi Arabia
10.6.3.1 Saudi Arabia antiseptic & disinfectant market, 2014 - 2026 (USD Million)

Chapter 11 Company Profiles
11.1 3M
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.2 Reckitt Benckiser Group plc
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.3 STERIS Plc
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Service benchmarking
11.4 Kimberly-Clark Corporation
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.5 Bio-Cide International, Inc.
11.5.1 Company overview
11.5.2 Product benchmarking
11.6 Cardinal Health
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.7 Novartis AG
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.8 BD
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.9 JOHNSON & JOHNSON
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M
  • Reckitt Benckiser Group plc
  • STERIS Plc
  • Kimberly-Clark Corporation
  • Bio-Cide International, Inc.
  • Cardinal Health
  • Novartis AG
  • BD
  • JOHNSON & JOHNSON
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751808
Adroll
adroll